Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07210567

Mindfulness-based Ecological Momentary Intervention for Smoking Cessation Among Cancer Survivors

The purpose of the study is to develop a new quit-smoking treatment among individuals with a cancer diagnosis using a smartphone app.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Smoking Cessation Behavior Health Behavior

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Institute for Nicotine & Tobacco Studies

New Brunswick, New Jersey, 08901, United States

Location status: Recruiting

About this study

The study aims to test the feasibility and acceptability of the smartphone app we developed in conjunction with face-to-face brief cessation counseling and nicotine replacement therapy in a two-arm randomized controlled trial.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ≥18 years old
  • smoked ≥1 cigarette per day (even one or two puffs) within the past 30 days
  • having been diagnosed with cancer
  • being motivated to quit in the next 30 days
  • having a valid home address and functioning phone number
  • being able to read, write, and speak English
  • having a smartphone that allows installation of the app
  • willingness to download the app

Exclusion criteria

  • being enrolled in a smoking cessation program
  • current use of smoking cessation medications
  • evidence of current psychosis
  • current/planning pregnancy or lactation

Treatment and study plan

Mindfulness

Behavioral

Participants will complete 4 counseling sessions (30 minutes), download and use a smartphone app for 4 weeks, complete 4 online surveys (baseline, quit date, end of treatment, and 3-month follow-up), and a brief phone call at the end of treatment to provide feedback. Participants will use the app every day to complete daily diaries and ecological momentary assessments (EMAs), receive brief mindful skills, and practice formal mindfulness meditations (5-30 minutes). Participants will also be provided with nicotine patches.

Quitline

Behavioral

Participants will be referred to Quitline to receive standard care smoking cessation treatment, including counseling and nicotine patches. Participants will complete 4 online surveys (baseline, quit date, end of treatment, and 3-month follow-up) and a brief phone call at the end of treatment to provide feedback. Participants will use the app every day to complete daily diaries.

Primary outcomes

  1. System Usablity Scale

    Time frame: End of Treatment at 4 Weeks

    Perceived usability and learnability of the app will be measured on a 5-point scale (1=strongly disagree; 5=strongly agree).

  2. Client Satisfaction Questionnaire

    Time frame: End of Treatment at 4 Weeks

    Perceived satisfaction with the treatment will be assessed on a 4-point scale (1=very dissatisfied; 4=very satisfied).

  3. Percentage of Participants That Completed Questionnaires

    Time frame: 3-month follow-up

    Completion of follow-up assessment will be calculated.

Study contacts

Contact information is provided by the study sponsor or research team.

Rutgers IRB/Human Research Protection Program

CONTACT

[email protected]

9739723608

Sponsors and collaborators

Lead sponsor

Rutgers, The State University of New Jersey

Other

Collaborators

  • National Cancer Institute (NCI)

Registry information

Important dates

Study start
2026
Primary completion
2027
Study completion
2028
First posted
Oct 7, 2025
Registry last updated
May 4, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.